A hybrid expressing genetically engineered major allergens of the Parietaria pollen as a tool for specific allergy vaccination (Q39343215)

11 September 2017

title

A hybrid expressing genetically engineered major allergens of the Parietaria pollen as a tool for specific allergy vaccination (English)

1 reference

11 September 2017

0 references

Bonura A

1 reference

11 September 2017

Corinti S

1 reference

11 September 2017

Artale A

1 reference

11 September 2017

Di Felice G

1 reference

11 September 2017

Amoroso S

1 reference

11 September 2017

Melis M

1 reference

11 September 2017

Geraci D

1 reference

11 September 2017

Colombo P

1 reference

11 September 2017

publication date

22 November 2006

1 reference

International Archives of Allergy and Immunology

11 September 2017

published in

1 reference

11 September 2017

volume

142

1 reference

11 September 2017

1 reference

11 September 2017

page(s)

274-284

1 reference

The role of outdoor air pollution and climatic changes on the rising trends in respiratory allergy

11 September 2017

cites work

1 reference

Signalling through the high-affinity IgE receptor Fc epsilonRI.

21 January 2018

1 reference

Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper

21 January 2018

1 reference

Inhibition of allergen-IgE binding to B cells by IgG antibodies after grass pollen immunotherapy

21 January 2018

1 reference

Allergen-specific immunotherapy with a monophosphoryl lipid A-adjuvanted vaccine: reduced seasonally boosted immunoglobulin E production and inhibition of basophil histamine release by therapy-induced blocking antibodies.

21 January 2018

1 reference

Renaissance of the blocking antibody concept in type I allergy

21 January 2018

1 reference

Allergen-specific nasal IgG antibodies induced by vaccination with genetically modified allergens are associated with reduced nasal allergen sensitivity

21 January 2018

1 reference

Vaccination with genetically engineered allergens prevents progression of allergic disease.

21 January 2018

1 reference

Urban air pollution and plant-derived respiratory allergy

21 January 2018

1 reference

cDNA cloning, expression and primary structure of Par jI, a major allergen of Parietaria judaica pollen

21 January 2018

1 reference

cDNA cloning, sequence analysis and allergological characterization of Par j 2.0101, a new major allergen of the Parietaria judaica pollen.

21 January 2018

1 reference

The recombinant major allergen of Parietaria judaica and its hypoallergenic variant: in vivo evaluation in a murine model of allergic sensitization

21 January 2018

1 reference

Identification of cross-reactive and genuine Parietaria judaica pollen allergens.

21 January 2018

1 reference

Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-gamma.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000097358

1 reference

11 September 2017

1 reference